Association of serious infections with pemphigus and pemphigoid: analysis of the Nationwide Inpatient Sample

Pemphigus and pemphigoid are blistering disorders associated with barrier disruption, immune dysregulation and use of immunosuppressing systemic therapy, all of which may predispose towards serious infections.

[1]  D. Whitham,et al.  Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost‐effectiveness analysis of the BLISTER trial , 2018, The British journal of dermatology.

[2]  J. Silverberg,et al.  Association of pemphigus and systemic corticosteroid use with comorbid health disorders: A case-control study. , 2017, Dermatology online journal.

[3]  K. Amber,et al.  Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis , 2017, JAMA dermatology.

[4]  K. Kridin,et al.  Is there an association between pemphigus and hepatitis viruses? A population-based large-scale study , 2017, Immunologic research.

[5]  J. Silverberg,et al.  Validation of International Classification of Disease Ninth Revision codes for atopic dermatitis , 2017, Allergy.

[6]  Enno Schmidt,et al.  Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial , 2017, The Lancet.

[7]  J. Silverberg,et al.  Association between atopic dermatitis and extracutaneous infections in US adults , 2017, The British journal of dermatology.

[8]  D. Murrell,et al.  The Reliability, Validity and Responsiveness of Two Disease Scores (BPDAI and ABSIS) for Bullous Pemphigoid: Which One to Use? , 2017, Acta dermato-venereologica.

[9]  J. Silverberg,et al.  Serious infections in hospitalized patients with psoriasis in the United States. , 2016, Journal of the American Academy of Dermatology.

[10]  Ş. Çoban,et al.  A Cutaneous Autoimmune Blistering Disorder Related to Chronic Hepatitis C: Bullous Pemphigoid , 2015, Journal of the American Geriatrics Society.

[11]  C. Llor,et al.  Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem , 2014, Therapeutic advances in drug safety.

[12]  M. Mokni,et al.  Human herpesvirus‐8 and hepatitis B and C virus infections in pemphigus , 2014, International journal of dermatology.

[13]  M. Ziv,et al.  Opportunistic infections in patients with pemphigus. , 2014, Journal of the American Academy of Dermatology.

[14]  J. Silverberg,et al.  Childhood atopic dermatitis and warts are associated with increased risk of infection: a US population-based study. , 2014, Journal of Allergy and Clinical Immunology.

[15]  J. Silverberg,et al.  Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization , 2013, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[16]  C. Lohse,et al.  Infection in autoimmune bullous diseases: A retrospective comparative study , 2013, The Journal of dermatology.

[17]  P. Noormohammadpour,et al.  Pemphigus Vulgaris and Infections: A Retrospective Study on 155 Patients , 2013, Autoimmune diseases.

[18]  C. Chams‐Davatchi,et al.  Quality of life and psychological status of patients with pemphigus vulgaris using Dermatology Life Quality Index and General Health Questionnaires , 2012, The Journal of dermatology.

[19]  J. Silverberg,et al.  Association between varicella zoster virus infection and atopic dermatitis in early and late childhood: a case-control study. , 2010, The Journal of allergy and clinical immunology.

[20]  R. Hubbard,et al.  A population‐based study of acute medical conditions associated with bullous pemphigoid , 2009, The British journal of dermatology.

[21]  H. Chraibi,et al.  Prédisposition aux infections des malades ayant un pemphigus : Étude rétrospective de 141 cas , 2007 .

[22]  R. Abouqal,et al.  [Predisposition to infection in patients with pemphigus. Retrospective study of 141 cases]. , 2007, Presse medicale.

[23]  M. Amine,et al.  Qualité de vie et pemphigus , 2005 .

[24]  S. Brenner,et al.  Pemphigus vulgaris: a review of treatment over a 19‐year period , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[25]  Yu-Huei Huang,et al.  Incidence, mortality, and causes of death of patients with pemphigus in Taiwan: a nationwide population-based study. , 2012, The Journal of investigative dermatology.

[26]  CM Torio,et al.  National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013: Statistical Brief #204 , 2006 .

[27]  H. Benchikhi,et al.  [Quality of life and pemphigus]. , 2005, Annales de dermatologie et de venereologie.